Publications by authors named "Christine Mantis"

Claim this Profile
U
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia.
Qi Jin, Carlos A Martinez, Kelly M Arcipowski, Yixing Zhu, Blanca T Gutierrez-Diaz, Christine Mantis

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Fraser Aird, Irawati Kandela, Christine Mantis,

Elife· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Christine Mantis, Irawati Kandela, Fraser Aird,

Elife· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Fraser Aird, Irawati Kandela, Christine Mantis,

Elife· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars.
Duncan Hieu M Dam, Kayla S B Culver, Irawati Kandela, Raymond C Lee, Kavita Chandra, Christine Mantis

Nanomedicine· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases.
Arno G Steinig, An-Hu Li, Jing Wang, Xin Chen, Hanqing Dong, Christine Mantis

Bioorg Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin.
Shripad V Bhagwat, Prafulla C Gokhale, Andrew P Crew, Andy Cooke, Yan Yao, Christine Mantis

Mol Cancer Ther· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer.
Eliot T McKinley, Joseph E Bugaj, Ping Zhao, Saffet Guleryuz, Christine Mantis

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2.
Andrew P Crew, Shripad V Bhagwat, Hanqing Dong, Mark A Bittner, Anna Chan, Christine Mantis

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis